Our Story
uMETHOD has developed a precision-medicine engine for chronic diseases. We’re bringing next-generation, personalized medicine to market. Using our technology, physicians can practice precision medicine and give patients the customized care that they need to transform their lives.
Our focus lies in helping individuals deal with chronic diseases which have multiple underlying medical causes. We apply sophisticated data-driven and artificial intelligence techniques, designed in collaboration with deep medical expertise, to create personalized care plans that address the underlying causes of chronic diseases to help improve care and outcomes.
Mission
Our mission is to provide hope to those who may have lost faith in finding solutions for complex, chronic diseases. We employ data to identify the underlying causes and develop evidence-based, personalized care plans. uMETHOD collaborates with patients, caregivers, and health care providers to help improve outcomes.
Leadership
uMETHOD was co-founded by COO Vik Chandra and CTO John Q. Walker, PhD. The founding team has deep experience in technology and business. uMETHOD is their 4th startup.
John Temperato
Mr. Temperato has extensive experience in executive management, corporate strategy, and global business development within the pharmaceutical and biotech industries. As President and CEO of 9 Meters Biopharma, he successfully led the creation of a Nasdaq-listed clinical-stage company through the merger of multiple entities, securing over $100 million in public financing and advancing innovative therapeutics for autoimmune and oncology diseases. Previously, as President and COO of Melinta Therapeutics, he executed strategic mergers and acquisitions, raised significant private equity funding, and implemented global commercialization strategies. His leadership at Salix Pharmaceuticals contributed to the company’s growth from $119 million to nearly $2 billion in revenue. Mr. Temperato holds a Bachelor of Science in Marketing from the University of Bridgeport and has a proven track record in developing high-impact partnerships, driving investor relations, and leading cross-functional teams to commercial success.
Vik Chandra
Mr. Chandra has deep experience in business strategy, product management, business development, and technology development. He led business strategy at IBM for solutions in Cloud and Service Management. In this role, he drove double-digit YTY profit growth. He was also responsible for driving business partnerships with other Fortune 500 vendors and for business cases for acquisitions. Mr. Chandra co-founded software startup neoButler Inc., where he led the R&D team focused on personalization services. His Masters in Computer Engineering is from North Carolina State University and he holds three technology patents.
John Q. Walker, Ph.D
Dr. John Q. Walker is the Chief Technology Officer (CTO) and a founder of uMETHOD Health. His specialty, as a systems engineer, is working closely with experts in other fields to build implementations of their highly complex visions. His collaboration with leading researchers is bringing precision medicine techniques to the care of neurological conditions. Two recent patents he received are for creating systems solutions for dementia and Alzheimer’s disease. Dr. Walker led pioneering software efforts in local-area networks (LANs), wireless LANs (“Wi-Fi”), high-speed networking, and voice-over-IP (VoIP) in advanced research-and-development teams at IBM. His doctorate in computer science is from UNC-Chapel Hill.
Dr. Ida Crocker-Sabbagh
Dr. Ida Crocker-Sabbagh is a board-certified family physician with over 30 years of clinical experience. She graduated Magna Cum Laude from the University of Arizona with a BS in Molecular and Cellular Biology and earned her MD from the University of Arizona College of Medicine in 1992. Dr. Crocker-Sabbagh has been in private practice since 2004, with a focus on concierge medicine, wellness, and prevention since 2011. Dr. Crocker-Sabbagh also launched the Women's Alzheimer's Prevention Clinic at the Cleveland Clinic Nevada in collaboration with the Women's Health Initiative. Her work was pivotal in developing protocols for the prevention of Alzheimer's disease in women, showcasing her expertise in addressing complex chronic diseases through via application of data and technology.
Paul Reder
Mr. Reder brings more than 30 years of software systems design and development knowledge to uMETHOD Health. His experience spans complex software products for large corporations to open-source software projects. He brings a breadth of experience on large and small projects including a heavy security focus and experience in all stages of design, development, and support, and holds seven software patents. Mr. Reder has a Bachelor of Science in Computer Science from the University of Central Florida and a Master of Science Degree in Computer Science from North Carolina State University.
Al Tarar
Afzal (“Al”) is the Founder, Chairman and Managing Partner of Arcis Capital Partners. Based in New York City, he leads the firm’s corporate development, engages with major investors and portfolio companies, and actively leads major investment deals. Prior to founding Arcis, Al was a partner at PricewaterhouseCoopers (“PwC”), one of the world’s largest accounting, tax, and advisory firms. He worked in PwC’s China/HK offices as well as New York City office. Over the past 25 plus years, Al has led extensive work across and advised clients on new ventures and M&A opportunities in the financial services, wealth and asset management, real estate, business services, and technology industries in the US, China/HK and broadly in Asia Pacific. Al received a BE degree from Tsinghua University in Beijing, China on an international cultural exchange scholarship, an MS degree from Case Western Reserve University in Cleveland, OH, and leadership development programs at Yale and INSEAD.
